The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Zakharova M.N.

Nauchnyĭ tsentr nevrologii RAMN, Moskva

Lysogorskaya E.V.

Neurology Research Center, Moscow, Russia

Trushnikova T.N.

GBOU VPO "Permskaia gosudarstvennaia meditsinskaia akademiia im. akad. E.A. Vagnera", Perm'

Zhelnin A.V.

GBOU VPO «Permskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. akad. E.A. Vagnera» Minzdrava RF;
GBUZ PK «Permskaja kraevaja klinicheskaja bolnitsa», Perm

The case-report of progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with natalizumab

Authors:

Zakharova M.N., Lysogorskaya E.V., Trushnikova T.N., Zhelnin A.V.

More about the authors

Read: 667 times


To cite this article:

Zakharova MN, Lysogorskaya EV, Trushnikova TN, Zhelnin AV. The case-report of progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with natalizumab. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(8‑2):107‑109. (In Russ.)
https://doi.org/10.17116/jnevro2018118082107

Recommended articles:
Surgical treatment of seco­ndary trigeminal neuralgia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):203-209
Quality of life of patients with multiple scle­rosis in the Smolensk region. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):36-40
Hormonal contraception methods and multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):24-30
Epidemiology of multiple scle­rosis in the city of Novo­sibirsk. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):119-127
Therapeutic options in patients with neuralgic amyotrophy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):39-45
A clinical case of X-linked adre­noleukodystrophy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):102-107

References:

  1. Carrillo-Infante C, Richman S, Yu B, Wenten M, Roberson A, Philip J, McIninch J, Richert N, Licata S, Ho P-R, Bloomgren G. Functional and survival outcomes of asymptomatic progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis patients: 2015 update. ECTRIMS Online Library. 2016;EP1528.
  2. Ho P-R, Koendgen H, Campbell N, Haddock B, Richman S, Chang J. Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies. Lancet Neurol. 2017;16(11):925-933. https://doi.org/10.1016/S1474-4422(17)30282-X
  3. Physician Information and Management Guidelines for Multiple Sclerosis patients on TYSABRI Therapy. European Medicines Agency. 2016. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Tysabri/human_referral_prac_000049.jsp&mid=WC0b01ac05805c516f
  4. Settipane GA, Pudupakkam RK, McGowan JH. Corticosteroid effect on immunoglobulins. J Allergy Clin Immunol. 1978;62(3):162-166.
  5. Butler WT, Rossen RD. Effects of corticosteroids on immunity in man. I. Decreased serum IgG concentration caused by 3 or 5 days of high doses of methylprednisolone. J Clin Invest. 1973;52(10):2629-2640.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.